Vaginal lactobacilli as potential probiotics against Candida spp by GIL, Natalia F. et al.
 6 
Brazilian Journal of Microbiology (2010) 41: 6-14 
ISSN 1517-8382 
 
VAGINAL LACTOBACILLI AS POTENTIAL PROBIOTICS AGAINST Candida spp. 
 
Natalia F. Gil1, Rafael C.R. Martinez1, Bruna C. Gomes1, Auro Nomizo1, Elaine C. P. De Martinis1* 
 
1Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil. 
 
Submitted: July 16, 2008; Returned to authors for corrections: April 09, 2009; Approved: September 28, 2009. 
 
ABSTRACT 
 
Urogenital infections affect millions of people every year worldwide. The treatment of these diseases usually 
requires the use of antimicrobial agents, and more recently, the use of probiotic lactic acid bacteria (LAB) 
cultures for the management of vaginal infections has been extensively studied. In this work, 11 vaginal 
lactobacilli isolates, previously obtained from healthy patients, were studied to screen microorganisms with 
probiotic properties against Candida spp. The LAB were tested for their ability of auto-aggregation, co-
aggregation with C. albicans, C. glabrata, C. krusei, and C. tropicalis, adhesion to Caco-2 epithelial cells and 
production of lactic acid and hydrogen peroxide (H2O2). All lactobacilli isolates tested were able to auto-
aggregate (ranging from 25.3% to 75.4% assessed at 4 hours of incubation) and to co-aggregate with the four 
Candida species into different degrees; among them L. crispatus showed the highest scores of co-
aggregation. The highest amount of lactic acid was produced by L. salivarius (13.9 g/l), followed by L. 
johnsonii (6.5 g/l), L. acidophilus (5.5 g/l), and L. jensenii (5.4 g/l). All isolates produced H2O2 , but the 
highest levels (3 - 10 mg/l) were observed for
 
L. acidophilus, L. crispatus, L. gasseri, L. johnsonii, and L. 
vaginalis. Only L. agilis, L. jensenii, L. johnsonii and L. ruminus were able to adhere to epithelial Caco-2 
cells. Among the isolates evaluated, L agilis, L. jensenii, L. johnsonii, and L. ruminus exhibited 
simultaneously several desirable properties as potential probiotic strains justifying future studies to evaluate 
their technological properties in different pharmaceutical preparations for human use.   
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INTRODUCTION 
 
In women of childbearing age, the vaginal ecosystem is 
dominated by Lactobacillus spp. (41). These microorganisms 
can prevent the colonization of the urogenital tract by several 
pathogens and they are important for women’s reproductive 
and general healthy (17, 24, 40, 42).  
 
Lactobacilli modulate the vaginal microbiota by different 
mechanisms such as: (i) auto-aggregation, (ii) production of 
lactic acid, hydrogen peroxide, bacteriocins, and biosurfactants, 
(iii) co-aggregation with pathogenic microorganisms, and (iv) 
adhesion to epithelial cells (17, 29, 37). 
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Bacterial vaginosis (BV) and vulvovaginal candidiasis 
(VVC) are the most prevalent vaginal infections worldwide 
(30). BV is responsible for up to 50% of all the cases of vaginal 
infections and it is characterized by a significant reduction in 
lactobacilli population, and increase in facultative aerobic and 
anaerobic pathogens (10, 16).  
VVC affects up to 75% of women at least once in their 
lives and despite pruritus and vaginal discharge are usual 
complaints associated with this disease neither is specific to the 
infection (34). The majority of cases of VVC (ca. 90%) caused 
by Candida albicans are treated with oral or topical antifungal 
agents, with increasing reports on episodes of VVC due to non-
albicans species (27, 28). There is an overgrowing concern 
about the spread use of over-the-counter preparations (such as 
topical azole agents) which may contribute for the selection of 
non-albicans resistant strains that are normally more difficult 
to be eradicated (23, 35).  
Probiotics are defined as live microorganisms which when 
administered in adequate quantity confer health benefits to the 
host and lactobacilli of human origin are potential probiotics 
against urogenital tract infections (11, 25). Some clinical 
studies showed positive results for the use of L. fermentum RC-
14 and L. rhamnosus GR-1 to treat patients with BV by oral 
intake and intravaginal administration (1, 2). Also, a recent 
clinical trial showed that oral administration of capsules 
containing L. fermentum RC-14 and L. rhamnosus GR-1 was 
effective as adjuvant in the treatment of patients diagnosed 
with VVC (20).  
Probiotics do not show collateral effects usually seen for 
traditional antibacterial and antifungal agents because they act 
by several mechanisms, which minimize punctual mutations 
involved in the emergence of antimicrobial resistant pathogens. 
The technology necessary to produce probiotic agents does not 
appear to be complex, and this can stimulate their production at 
reasonable costs. This scenario certainly encourages more 
researches to be undertaken to select and test new strains with 
probiotic properties. 
The aim of the present work was to evaluate the ability of 
Lactobacillus spp., previously isolated from the vaginal 
microbiota of healthy Brazilian patients, as potential probiotics 
against Candida species.  
 
MATERIALS AND METHODS 
 
Strains 
A total of 11 vaginal Lactobacillus spp. were previously 
isolated from a group of 64 healthy Brazilian women (21) and 
the use of the strains for this study was approved by local Ethic 
Review Board (250/CEP-CSE-FMRP-USP). The isolates 
studied were L. acidophilus, L. agilis, L. coleohominis, L. 
crispatus, L. fermentum, L. gasseri, L. jensenii, L. johnsonii, L. 
salivarius, L. ruminus and L. vaginalis. Additionally, for the 
study of adhesion to epithelial cells, L. bulgaricus and L. 
rhamnosus GG were employed as negative and positive 
controls, respectively. The bacterial strains were kept at - 70°C 
in MRS broth (de Man, Rogosa and Sharpe – Oxoid, UK) 
added of 20 % (v/v) of glycerol.  
A total of four Candida spp. strains were used in this 
study, to know: C. albicans ATCC 18804, C. tropicalis ATCC 
750, C. krusei ATCC 20298 and C. glabrata ATCC 2001. The 
yeast strains were kept in SDA (Sabouraud-dextrose agar – 
Oxoid, UK) at room temperature.  
 
Auto-aggregation studies  
Lactobacillus spp. was grown overnight at 37ºC in MRS 
broth (1.0%, v/v), centrifuged at 6,000g for 15min (Fanem, 
mod. 208 N, Brazil) and cell pellets were resuspended in 
phosphate buffered saline (PBS) to obtain an optical density 
(O.D.) of 0.6 at 600nm (UVmini-1240, Shimadzu, Japan). 
Auto-aggregation inversely correlated with O.D. and it was 
monitored every 1h for up to 4h of incubation (13, 25). Gram 
staining was used to visualize the aggregates under oil 
immersion microscopy with 100 times magnification (CX-31 – 
Olympus, Japan). 
 
Co-aggregation studies  
Culture plates of 24 wells containing round glass slides 
were added of: i) 500µL of an overnight culture of 
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Lactobacillus spp. grown at 37oC in MRS broth and ii) 
500µL of an overnight culture of Candida spp. grown at 37oC 
in BHI broth (Brain-Heart Infusion – Oxoid, UK). Plates were 
incubated at 37oC for 4h in an orbital shaker at 100 rpm (CT-
712, Cientec, Brazil) and co-aggregation was determined by 
Gram staining of the round glass slides and observation under 
oil immersion microscopy (CX-31 – Olympus, Japan). Scoring 
was done according to Reid et al. (31). 
 
Production of lactic acid 
Homofermentative metabolism was verified by absence of 
production of gas from glucose (33) and lactic acid production 
was quantified in grams per liter, by acid-base titration, 
according to Edema and Sanni (9). 
 
Production of hydrogen peroxide 
Determination of hydrogen peroxide (H2O2) production by 
Lactobacillus isolates was performed according to Wilks et al. 
(41) with modifications. Briefly, lactobacilli were grown in 
MRS broth (Oxoid, UK) for 24h at 37ºC and 100µl-aliquots of 
the broths were seeded on MRS agar plates (Oxoid, UK) and 
incubated for 48h at 37ºC, under anaerobic atmosphere. 
Selected colonies were put in contact with strips containing 
peroxidase (Merckoquant Peroxide Test - Merck, Germany). 
Different tones of blue products were visually compared, with 
a scale provided by the manufacturer. Results were expressed 
in ranges of H2O2 production according to Wilks et al. (41).  
 
Adhesion to the epithelial cells 
Adhesion to intestinal epithelial Caco-2 cells (ATCC 
7348406) was evaluated according to Duprè et al. (8). Briefly, 
Caco-2 cells were cultivated at 37°C under 5% CO2 in RPMI 
medium (Gibco, USA) supplemented with 10% of fetal bovine 
serum and 100U/ml of streptomycin and penicillin (Sigma, 
USA). When confluent growth was achieved, adhered cells 
were trypsinized, transferred to 24-well plates containing round 
glass slides and re-incubated. After 24 hours, the RPMI 
medium with antibiotics was removed and replaced by RPMI 
supplemented with 2% of fetal bovine serum. Bacterial cultures 
were previously grown overnight at 37°C in MRS broth, 
diluted in RPMI containing 2% of fetal bovine serum and 
added to each well (ca. 106 bacteria) containing the Caco-2 
cells and incubation was done at 37°C for 3 hours. After that, 
slides were washed, fixed, stained with May–Grunwald–
Giemsa and analyzed under oil immersion microscopy with 
100 times magnification (CX-31 – Olympus, Japan). 
The number of bacteria adhered to Caco-2 cells was 
obtained by scoring adhesion to 100 random eukaryotic cells, 
using criteria proposed by Del Re et al. (7) as non-adhesive (<5 
bacteria/100 cells), adhesive (6-40 bacteria/100 cells) and 
strongly adhesive (>40 bacteria/100 cells). L. bulgaricus and L. 
rhamnosus GG were used as negative and positive controls, 
respectively.  
 
RESULTS AND DISCUSSION 
 
All lactobacilli isolates tested in the present study 
exhibited some degree of auto-aggregation at all time-points 
tested, but the highest degree of auto-aggregation was observed 
after 4h of incubation at 37°C for L. jensenii, followed by L. 
ruminus and L. acidophilus (Figure 1). Figure 1 also illustrates 
auto-aggregation observed for L. acidophilus in two time-
points. The ability of auto-aggregation of vaginal lactobacilli is 
an intrinsic characteristic and may substantially increase the 
colonization of environments with short residence times (25). 
According to Juarez-Tomás et al. (13) the ability of auto-
aggregation is higher in acid environments where probiotic 
lactobacilli are more adapted to survive and represents the first 
step towards the formation of biofilms by lactobacilli strains, 
which helps to inhibit the overgrowth and proliferation of 
pathogenic microorganisms (14, 37).  
The co-aggregation scores obtained after 4h of incubation 
at 37°C for Lactobacillus spp. and Candida spp. are shown in 
Table 1 and illustrated in Figure 2. L. crispatus showed 
macroscopically visible clumps when evaluated with all four 
Candida strains. The co-aggregation can create a 
microenvironment around the pathogen with a higher 
concentration of inhibitory substances and it can also block the 
dissemination of pathogens to tissue receptors (22, 29). 
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Figure 1. Auto-aggregation of Lactobacillus spp. evaluated in a 4-hour study (A) and microphotographies (magnification of 
1000x) showing specifically auto-aggregation of L. acidophilus assessed after 1h (B) and 4h (C) of incubation at 37oC. 
 
Table 1. Co-aggregation scores obtained with Lactobacillus spp. and Candida spp. at 4h of incubation at 37oC, according 
classification of Reid et al. (31)* 
 C. albicans C. glabrata C. krusei C. tropicalis 
 
L. acidophilus 
 
3 
 
3 
 
2 
 
3 
L. agilis 1 3 2 3 
L. coleohominus 3 3 4 4 
L. crispatus 4 4 4 4 
L. fermentum 4 4 3 3 
L. gasseri 1 1 3 3 
L. jenssenii 1 3 3 2 
L. johnsonii 3 4 3 2 
L. ruminus 4 3 2 3 
L. salivarius 3 1 4 2 
L. vaginalis 3 4 2 4 
*No aggregation (0); small aggregates with small visible clusters of bacteria (1); aggregates with larger numbers of bacteria (2); 
macroscopically visible clumps with larger groups of bacteria settled in the center of the well (3) and macroscopically visible clumps (4). 
B C 
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Figure 2.  Microphotographies (magnification of 1000x) showing co-aggregation between C. albicans x L gasserii (A), C. krusei 
x L. vaginalis (B), C. albicans x L. johnsonii (C) and C. albicans x L. ruminus (D) assessed after 4h of incubation at 37oC, and 
respectively scored as: small aggregates with small visible clusters of bacteria (1); aggregates with larger numbers of bacteria (2); 
macroscopically visible clumps with larger groups of bacteria settled in the center of the well (3) and macroscopically visible 
clumps (4) according to Reid et al. (31).  
 
 
 
The results for quantification of lactic acid produced by 
the lactobacilli isolates are summarized in Table 2. The highest 
amount of lactic acid was produced by L. salivarius, followed 
by L. johnsonii, L. acidophilus and L. jensenii. The production 
of organic acids helps to keep the vaginal pH below 4.5 and 
creates a hostile environment for the growth and survival of 
pathogenic microorganisms (3).  In a study conducted by 
Valore et al. (40) with vaginal exudates samples obtained from 
healthy patients, a higher antimicrobial activity was verified for 
samples with the highest levels of lactic acid. 
Hydrogen peroxide is another antagonistic compound 
produced by lactobacilli and its production is normally 
assessed by using qualitative methods, such as incorporation of 
the peroxide in agar medium and revelation by addition of 
tetramethylbenzidine (19, 24). However, quantitative results 
may help to better understand the role of H2O2 in healthy and 
infected vaginal environments (38, 41). In this study, despite 
H2O2 production by all isolates, the highest levels were 
observed for
 
L. acidophilus, L. crispatus, L. gasseri, L. 
johnsonii, and L. vaginalis (Table 3). 
In vaginal exudates, H2O2 is converted to reactive oxygen 
species (ROS) such as superoxide anions, hydrogen peroxide 
and hidroxyl free radicals that are highly toxic against several 
microorganisms (15). Besides that, lactobacilli keep a high oxi-
reduction potential in the vaginal environment, which inhibits 
multiplication of strictly anaerobic bacteria (3). The absence 
hydrogen peroxide-producing lactobacilli has been related to a 
higher risk of BV, recurrent urinary tract infection by E. coli 
D 
A B 
C 
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and increased susceptibility to the infection by Human 
Immunodeficiency Virus (HIV-1) (31, 38). 
 
Table 2. Lactic acid production by vaginal Lactobacillus spp. 
isolates, expressed in g/l 
 
 
     Species 
 
     Lactic acid (g/l)* 
 
L. acidophilus 5.52 
L. agilis 1.72 
L. coleohominis 0.77 
L. crispatus 1.32 
L. fermentum 1.22 
L. gasseri 1.35 
L. jensenii 5.42 
L. johsonii 6.50 
L. ruminus 1.22 
L. salivarius 13.95 
L. vaginalis 1.72 
*According to Edema and Sanni (9) 
 
 
 
 
Table 3. Semi-quantification of H2O2 production by vaginal 
Lactobacillus spp. isolates obtained from healthy patients 
 
Production of H2O2 (mg/l)* 
 
1-3 
 
   3-10 
 
L. agilis 
L. colehominis 
L. fermentum 
L. jensenii 
L. ruminus 
L. salivarius 
L. acidophilus 
L. crispatus 
L. gasseri 
L. johnsonii 
L. vaginalis 
 
*Production of H2O2 was scored according to Wilks et al. (41) as: 
negative, 1-3, 3-10, 10-30, 30-100 mg/l of H2O2.   
 
 
Atassi et al. (4) affirmed that adhesion to epithelial tissue 
is the first step towards the formation of a barrier by 
lactobacilli that will prevent colonization by pathogenic 
microorganisms. In our study lactobacilli isolates were tested 
for adhesion to epithelial tissue, using Caco-2 cell, which 
presents a confluent growth when cultivated in vitro and shows 
characteristics of mature enterocytes, making it an excellent 
model for studying adherence of microorganisms (6, 12). 
Among all lactobacilli isolates tested, only L. agilis, L. jensenii, 
L. johnsonii and L. ruminus were able to adhere to epithelial 
Caco-2 cells (Table 4 and Figure 3) indicating adhesion is 
specific for each bacterial strain, as verified also by Chauvière 
et al. (6).  
Some vaginal Lactobacillus species are capable of 
synthesizing antimicrobial peptides known as bacteriocins (5). 
In our study, we have also evaluated bacteriocin production of 
all lactobacilli isolates against Candida strains by agar 
antagonism method, but no inhibitory activity was detected 
(data not shown). Osset et al. (26) studied the production of 
bacteriocin by several LAB isolates against C. albicans and C. 
glabrata and they did not observe inhibition zones when agar 
plate method was used. However, in broth cultures those 
authors verified that some lactobacilli were inhibitory against 
C. albicans to some extent. In our experiments, highest 
inhibitory activity against C. albicans assessed in BHI broth 
was obtained for both L. jensenii and L. johnsonii isolates (data 
not shown).  
Ström et al. (36) observed that several antifungal 
compounds, such as cyclic dipeptides, pyroglutamic acid and 
lactones were produced by Lactobacillus isolates and played an 
important role against Candida spp. Thus further investigation 
is required to clarify the nature of the inhibitory substance 
produced by lactobacilli isolates against the yeast in our study.   
In conclusion, our results indicated that among the 11 
vaginal lactobacilli isolates tested, L agilis, L. jensenii, L. 
johnsonii, and L. ruminus exhibited desirable properties as 
potential probiotic strains including the ability to adhere to 
epithelial mucosa, to auto-aggregate, co-aggregate with 
Candida species, and to produce both lactic acid and H2O2. 
Also, future studies are encouraged to assess technological 
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properties of those microorganisms for clinical use, including 
determination of their viability and stability in pharmaceutical 
preparations such as capsules resistant to gastrointestinal tract 
for oral intake and ovules/capsules for intravaginal 
administration. 
 
 
Table 4. Classification of adhesion of vaginal isolates of Lactobacillus spp. to Caco-2 cells 
Non-adhesive* 
(<5 bacteria/100 Caco-2 cells) 
 Adhesive* 
(6-40 bacteria/100 Caco-2 cells) 
L. acidophilus 
L. colehominis 
L. crispatus 
L. fermentum 
L. gasseri 
L. salivarius 
L. vaginalis 
L. bulgaricus¥ 
L. agilis 
L. jensenii 
L. johnsonii 
L. ruminus 
L. rhamnosus¥ 
*Adhesion was classified according to Del Re et al. (7). ¥L. bulgaricus and L. rhamnosus GG were used as negative and positive 
controls, respectively. 
 
 
 
Figure 3. Microphotographies (magnification of 1000x) showing adhesion of L. rhamnosus (A), L. bulgaricus (B), and L. agilis 
(C) to the epithelial Caco-2 cell line. 
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